Table 3.
Some examples of GN diagnoses
(1) IgA nephropathy |
Primary diagnosis: IgA nephropathy |
Pattern of injury: diffuse mesangial and focal segmental endocapillary proliferative and sclerosing GN |
Score/grade: Oxford classification: M1 E1 S1 T1 |
Additional features: focal global glomerulosclerosis (20%), moderate tubular atrophy and interstitial fibrosis (30%), mild arteriosclerosis and hyaline arteriolosclerosis |
Secondary diagnoses: diabetic nephropathy, mild |
(2) Lupus nephritis |
Primary diagnosis: (1) lupus nephritis and (2) thrombotic microangiopathy |
Pattern of injury: diffuse proliferative and sclerosing GN with focal (10%) cellular crescents |
Score/grade: ISN/RPS class IV-G (A/C) |
Additional features: thrombotic microangiopathy associated with antiphospholipid antibodies/clinical, focal global glomerulosclerosis (10%), mild tubular atrophy and interstitial fibrosis (10%), moderate arteriosclerosis, and moderate hyaline arteriolosclerosis |
(3) Hepatitis C–associated immune–complex GN |
Primary diagnosis: immune-complex GN |
Pattern of injury: membranoproliferative GN |
Additional features: with features of cryoglobulinemic GN (hepatitis C/clinical), focal global glomerulosclerosis (20%), moderate tubular atrophy and interstitial fibrosis (30%), moderate arteriosclerosis, and moderate hyaline arteriolosclerosis |
(4) Infection-related GN |
Primary diagnosis: IgA–dominant infection–related GN |
Pattern of injury: diffuse exudative GN |
Additional features: associated with S. aureus cellulitis infection/clinical, focal global glomerulosclerosis (30%), moderate tubular atrophy and interstitial fibrosis (30%), moderate arteriosclerosis, and moderate hyaline arteriolosclerosis |
Secondary diagnoses: diabetic nephropathy, moderate |
(5) ANCA GN |
Primary diagnosis: proteinase 3-ANCA GNa |
Pattern of injury: necrotizing and crescentic GN |
Prognostic class: focal (≥50% normal glomeruli) |
Additional features: clinicopathologic features of granulomatosis with polyangiitis (proteinase 3 and cytoplasmic ANCA/clinical), focal global glomerulosclerosis (10%), mild tubular atrophy and interstitial fibrosis (10%), mild arteriosclerosis, and moderate hyaline arteriolosclerosis |
(6) Anti-GBM GN |
Primary diagnosis: anti-GBM GN |
Pattern of injury: necrotizing and crescentic GN, severe |
Additional features: clinicopathologic features of Goodpasture syndrome (anti-GBM antibody/clinical), focal global glomerulosclerosis (40%), moderate tubular atrophy and interstitial fibrosis (40%), mild arteriosclerosis, and moderate hyaline arteriolosclerosis |
(7) Monoclonal Ig GN |
Primary diagnosis: monoclonal Ig GN |
Pattern of injury: membranoproliferative GN with intracapillary hyaline thrombi (pseudothrombi) |
Additional features: IgM κ-staining of glomerular intracapillary deposits consistent with type 1 cryoglobulins (Waldenström macroglobulinemia/type 1 cryoglobulins/clinical), focal global glomerulosclerosis (30%), moderate tubular atrophy and interstitial fibrosis (40%), moderate arteriosclerosis, and moderate hyaline arteriolosclerosis |
(8) C3 glomerulopathy |
Primary diagnosis: C3 GN |
Pattern of injury: membranoproliferative GN |
Additional features: focal global glomerulosclerosis (20%), mild tubular atrophy and interstitial fibrosis (20%), mild arteriosclerosis, and moderate hyaline arteriolosclerosis |
ISN/RPS, International Society of Nephrology/Renal Pathology Society; A/C, active/chronic.
If MPO/PR3 titers are not known, it is acceptable to label as ANCA GN.